Literature DB >> 3828955

Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors.

E R Fisher, R Sass, B Fisher.   

Abstract

Pathologic materials were available for review from 1597 women with Stage II (positive regional node metastases) invasive breast cancer in whom estrogen receptor (ER) and progesterone receptor (PR) assays of the primary tumor were performed. These women were enrolled in a clinical trial comparing the effect of postmastectomy adjuvant L-phenylalanine mustard (L-PAM) and 5-fluorouracil (5-FU) with and without tamoxifen (NSABP Protocol No. 9). Significant pathologic and clinical associations with receptor status were similar for both ER and PR except that the latter, unlike ER, was not related to patient age. Regression analyses revealed that the most significant pathologic features related to a concordant positive ERPR receptor status was low (well differentiated) nuclear and histologic grades, slight or absent tumor lymphoid infiltrate, slight or absent necrosis and moderate or marked elastica in decreasing order of importance. All of the factors enumerated are directly or indirectly related to tumor differentiation. Recognition of four or five conforming pathologic features allows for the prediction of either ER or PR status in 70% to 80% of instances respectively, and the presence of three features in 69%. This latter figure is similar to that of estimation of nuclear grade alone. Thirty percent of ERPR estimates were discordant i.e., either ER-PR+ or ER+PR-. Pathologic features associated with discordant assays were not similar to those found when the ERPR estimates were concordant. Life table analyses revealed patients with discordant receptors to exhibit disease-free survival intermediate to that of those with ER+PR+ and ER-PR- values. This information suggests that a discordant receptor status is more reflective of an aberration of ER metabolism than a methodologic error. Histograms correlating frequency of nuclear grades with levels of ER and PR were comparable and revealed patterns indicating the propriety of relating values less than 10 fm/mg as being receptor negative. The frequency of well-differentiated nuclei increased with ascending levels of ER and PR.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828955     DOI: 10.1002/1097-0142(19870501)59:9<1554::aid-cncr2820590904>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Medullary cancer of the breast revisited.

Authors:  E R Fisher; J P Kenny; R Sass; N V Dimitrov; R H Siderits; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

2.  Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry.

Authors:  B Helpap
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

3.  Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.

Authors:  Elizabeth N Kornaga; Alexander C Klimowicz; Natalia Guggisberg; Travis Ogilvie; Don G Morris; Marc Webster; Anthony M Magliocco
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

4.  Charity Hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional disease.

Authors:  C M Sutherland; F J Mather
Journal:  Ann Surg       Date:  1988-05       Impact factor: 12.969

5.  Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.

Authors:  H O Wintzer; M Benzing; S von Kleist
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

Review 6.  Canine mammary tumors as a model for human disease.

Authors:  Somaia M Abdelmegeed; Sulma Mohammed
Journal:  Oncol Lett       Date:  2018-04-02       Impact factor: 2.967

7.  Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states.

Authors:  G R Rutteman; W Misdorp; M A Blankenstein; W E van den Brom
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

8.  Estrogen receptors genotypes and canine mammary neoplasia.

Authors:  Ana Canadas-Sousa; Marta Santos; Bárbara Leal; Rui Medeiros; Patrícia Dias-Pereira
Journal:  BMC Vet Res       Date:  2019-09-10       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.